NeuroRx Research Inc. / Biostatistics / SPONSOR PRESENTATIONS Genzyme Corporation / Genzyme Corporation / Risk Management Office / Sanofi Company / MPH Group / /
Facility
Clinic Foundation Pharmacology / Mellen Center / Montreal Neurological Institute / Meeting Sheraton Silver Spring Hotel / Cypress Ballroom / Neurology University of Texas / Public Health University of Alabama / /
MedicalCondition
Therapeutic Area Head Multiple Sclerosis / multiple sclerosis / MS / /
NaturalFeature
Genzyme Stephen Lake / /
Organization
Peripheral and Central Nervous System Drugs Advisory Committee / Risk Management office of Medication Error / office of New Drugs / FOOD AND DRUG ADMINISTRATION / Medication Error and Risk Management office of Surveillance / Montreal Neurological Institute / Case Western Reserve University / Biostatistics Office / McGill University / Center for Drug Evaluation and Research / University of Alabama at Birmingham / Division of Neurology Products / Central Nervous System Drugs Advisory Committee / University of Texas / /
Person
John Marler / Safety Evelyn Mentari / Multiple Sclerosis / Edward Fox / Alemtuzumab Efficacy Sharon Yan / Michael Panzara / Nyedra W. Booker / Introductory Remarks Eric Bastings / Glendolynn S. Johnson / Nathan Fountain / David Margolin / Jennifer Panagoulias / /
Position
Professor of Neurology / Acting Director / CEO / Risk Management Analyst Division / President / Director / Central Texas Neurology Consultants Clinical Assistant Professor / Director / Regulatory Affairs / Director / Clinical Research Genzyme Stephen Lake / ScD Senior Director / Chairperson / PharmD Designated Federal Officer / Professor of Biostatistics / Director / Mellen Center / Senior Medical Director / Clinical Research / VP / Therapeutic Area Head / Director / /